 Lexicon Pharmaceuticals LXRX news for Tuesday includes LXRX stock soaring higher on results from a Phase 3 clinical trial. The post Lexicon Pharmaceuticals News: Why LXRX Stock Is Soaring 43 Today appeared first on InvestorPlace. 